References
- Ahn MY, Shin KH, Kim DH, Jung EA, Toida T, Linhardt RJ, et al.1998. Characterization of a Bacteroides species from human intestine that degrades glycosaminoglycans. Can. J. Microbiol. 44: 423−429. https://doi.org/10.1139/cjm-44-5-423
- Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248−254. https://doi.org/10.1016/0003-2697(76)90527-3
- Ernst S, Langer R, Cooney CL, Sasisekharan R. 1995. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30: 387−444. https://doi.org/10.3109/10409239509083490
- Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, et al. 1999. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19: 8778−8788.
- Hong SW, Kim BT, Shin HY, Kim WS, Lee KS, Kim YS, et al. 2002. Purification and characterization of novel chondroitin ABC and AC lyases from Bacteroides stercoris HJ-15, a human intestinal anaerobic bacterium. Eur. J. Biochem. 269: 2934−2940. https://doi.org/10.1046/j.1432-1033.2002.02967.x
- Ingber DE. 1989. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell. Biol. 109: 317−330. https://doi.org/10.1083/jcb.109.1.317
- Jackson RL, Busch SJ, Cardin AD. 1991. Glycosaminoglycans; molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71: 481−539. https://doi.org/10.1152/physrev.1991.71.2.481
- Johnson SL, Daligault HE, Davenport KW, Jaissle J, Frey KG, Ladner JT, et al. 2015. Thirty-two complete genome assemblies of nine Yersinia species, including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica., Genome. Announc. 3: e00148(15). https://doi.org/10.1128/genomeA.00148-15
- Patwari P, Kurz B, Sandy JD, Grodzinsky AJ. 2000. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. Arch. Biochem. Biophys. 374: 79−85. https://doi.org/10.1006/abbi.1999.1538
- Plass AH, Wong-Palms S, Roughley PJ, Midura RJ, Hascall VC. 1997. Chemical and immunological assay of the nonreducing terminal residues of chondroitin sulfate from human aggrecan. J. Biol. Chem. 272: 20603−20610. https://doi.org/10.1074/jbc.272.33.20603
- Plass AH, West LA, Wong-palms S, Nelson FR. 1998. Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate. J. Biol. Chem. 273: 12642−12649. https://doi.org/10.1074/jbc.273.20.12642
- Prabhakar V, Capila I, Soundararajan V, Raman R, Sasisekharan R. 2009. Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgaris. J. Biol. Chem. 284: 974−982. https://doi.org/10.1074/jbc.M806630200
- Shaya D, Hahn BS, Park NY, Sim JS, Kim YS, Cygler M. 2008. Characterization of chondroitin sulfate lyase ABC from Bacteroides thetaiotaomicron WAL2926. Biochem. J. 47: 6550−6661.
- Shim KW, Kim DH. 2007. Cloning and expression of chondroitinase AC from Bacteroides stercoris HJ-15. Protein. Expr. Purif. 58: 222−228.
- Smith-Thomas LC, Stevens J, Fok-Seang J, Faissner A, Rogers JH, Fawcett JW. 1995. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J. Cell. Sci. 108: 1307−1315.
- Voldavsky I, Fuks Z, Isai-Michaeli R, Bashkin P, Levi E, Korner G, et al. 1991. Extracellular matrix resident basic fibroblast growth factor: Implication for the control of angiogenesis. J. Cell. Biochem. 45: 167−176. https://doi.org/10.1002/jcb.240450208